Inspector General Robert P. Storch announced today that the Department of Defense Office of Inspector General (DoD OIG) released the management advisory, “The DoD Should Analyze the Use of Barcode Scanners for Conducting Inventories of Defense Articles Requiring Enhanced End-Use Monitoring.” This management advisory is part of an ongoing series of reviews evaluating the DoD’s efforts to monitor and account for defense articles subject to enhanced end-use monitoring (EEUM) provided to the Ukrainian Armed Forces.

Statement of Brett Mansfield, Deputy Inspector General for Audit, Department of Defense for the hearing on “Tracking Progress: Examining the Department of Defense’s Financial Management Practices” with the Committee on Oversight and Accountability, September 24, 2024.

Inspector General Robert P. Storch announced today that the Department of Defense Office of Inspector General (DoD OIG) released the “Audit of the E-2D Advanced Hawkeye Capabilities.”

The objective of this attestation was to assist the Office of Personnel Management (OPM) in assessing whether retirement, health benefits, and life insurance withholdings and contributions, as well as enrollment information submitted through the Semiannual Headcount Report by the Defense Finance and Accounting Service for FY 2024, were reasonable.

On September 25, 2024, the Department of Defense Office of Inspector General (DoD OIG) completed a quality assessment review of the Defense Health Agency Office of the Inspector General (DHA OIG).

Statement of Brett Mansfield, Deputy Inspector General for Audit, Department of Defense for the hearing on “Tracking Progress: Examining the Department of Defense’s Financial Management Practices” with the Committee on Oversight and Accountability, September 24, 2024.

Jacob Liticker, 27, of Houston, Texas was sentenced to two years in federal prison after pleading guilty to conspiracy to commit wire fraud. Liticker was charged in the District of South Carolina for his role in a national fraud scheme related to the Coronavirus Aid, Relief, and Economic Security Act’s Paycheck Protection Program (PPP). During the height of the COVID-19 pandemic, Congress authorized the PPP program to provide emergency economic relief to businesses suffering economic harm during and as a result of the pandemic.

Precision Toxicology, doing business as Precision Diagnostics, has agreed to pay $27 million to resolve alleged violations of the False Claims Act and similar state statutes for billing Medicare, Medicaid and other federal health care programs for medically unnecessary urine drug tests, and for providing free items to physicians who agreed to refer expensive laboratory testing business to Precision. Precision, headquartered in San Diego, is one of the nation’s largest urine drug testing laboratories.

Former hospital chief executive officer (CEO) Jeffrey Madison, of Georgetown, Texas, has agreed to pay $5,343,630 to resolve allegations under the False Claims Act involving illegal payments to physicians for laboratory referrals in violation of the Anti-Kickback Statute. Madison also has agreed to cooperate with the Justice Department’s investigations of, and litigation against, other participants in the alleged schemes.